News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>Nomura Mildly Cuts WUXI BIO's TP to HKD34.23, Rating Buy
Nomura has released a research report predicting a rebound in growth for WUXI BIO (02269.HK) in 1H25, with revenue/ net profit expected to increase by 13.8%/ 24.7% YoY, mainly due ...
Reset
Send
The window will close in 5 seconds
<Research>Nomura Mildly Cuts WUXI BIO's TP to HKD34.23, Rating Buy
Close
Recommend
12
Positive
18
Negative
9
 
SHORT SELL
 
STOCK INFO

Nomura has released a research report predicting a rebound in growth for WUXI BIO (02269.HK)  +1.150 (+4.228%)    Short selling $131.61M; Ratio 15.860%   in 1H25, with revenue/ net profit expected to increase by 13.8%/ 24.7% YoY, mainly due to a lower base in 1H24. It is likely that a similar trend will continue in 2HFY25.

In addition, Nomura considered the strong growth of WUXI XDC (02268.HK)  +1.400 (+2.869%)    Short selling $14.77M; Ratio 6.959%   , a subsidiary of WUXI BIO with a Buy rating, as a major growth driver for WUXI BIO. Excluding WUXI XDC, the broker estimated the sales growth to be around 6%.

Related NewsPing An Securities Recommends Eyeing 3 Key Themes amid Spreading 'Anti-Involution' Rally
Nomura kept a Buy rating on WUXI BIO and slightly lowered its target price from HKD34.36 to HKD34.23, implying a 28% upside potential.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-07-17 12:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.